Ningbo Menovo Pharm Co Ltd (603538) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Ningbo Menovo Pharm Co Ltd (603538) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥38.86 Million ≈ $5.69 Million USD) by net assets (CN¥2.42 Billion ≈ $353.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Ningbo Menovo Pharm Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Ningbo Menovo Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Ningbo Menovo Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ningbo Menovo Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ningbo Menovo Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Jiahua Energy Chemical Industry Co Ltd SHG:600273	0.025x
Doosan Pref Shs KO:000155	0.010x
Yantai China Pet Foods Co Ltd SHE:002891	0.000x
HBIS Resources Co Ltd SHE:000923	0.010x
Zhejiang Jolly Pharmaceutical Co Ltd SHE:300181	-0.007x
Unitech Printed Circuit Board Corp TW:2367	-0.032x
Elecon Engineering Company Limited NSE:ELECON	0.072x
Nabors Industries Ltd. NYSE:NBR	0.079x

Annual Cash Flow Conversion Efficiency for Ningbo Menovo Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Ningbo Menovo Pharm Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Ningbo Menovo Pharm Co Ltd (603538) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.45 Billion ≈ $358.64 Million	CN¥157.56 Million ≈ $23.06 Million	0.064x	+51.03%
2024-12-31	CN¥2.29 Billion ≈ $335.31 Million	CN¥97.54 Million ≈ $14.27 Million	0.043x	+918.66%
2023-12-31	CN¥2.19 Billion ≈ $319.83 Million	CN¥9.13 Million ≈ $1.34 Million	0.004x	-96.72%
2022-12-31	CN¥2.17 Billion ≈ $318.01 Million	CN¥276.95 Million ≈ $40.53 Million	0.127x	+14.28%
2021-12-31	CN¥1.98 Billion ≈ $289.52 Million	CN¥220.63 Million ≈ $32.28 Million	0.112x	-21.89%
2020-12-31	CN¥1.76 Billion ≈ $257.91 Million	CN¥251.61 Million ≈ $36.82 Million	0.143x	+24.57%
2019-12-31	CN¥1.57 Billion ≈ $229.52 Million	CN¥179.75 Million ≈ $26.30 Million	0.115x	+229.61%
2018-12-31	CN¥1.34 Billion ≈ $196.11 Million	CN¥46.60 Million ≈ $6.82 Million	0.035x	-49.57%
2017-12-31	CN¥1.16 Billion ≈ $170.11 Million	CN¥80.15 Million ≈ $11.73 Million	0.069x	-57.01%
2016-12-31	CN¥731.02 Million ≈ $106.97 Million	CN¥117.24 Million ≈ $17.16 Million	0.160x	-22.37%
2015-12-31	CN¥645.81 Million ≈ $94.50 Million	CN¥133.42 Million ≈ $19.52 Million	0.207x	+55.00%
2014-12-31	CN¥564.34 Million ≈ $82.58 Million	CN¥75.22 Million ≈ $11.01 Million	0.133x	-56.46%
2013-12-31	CN¥487.44 Million ≈ $71.33 Million	CN¥149.21 Million ≈ $21.83 Million	0.306x	+255.52%
2012-12-31	CN¥442.58 Million ≈ $64.76 Million	CN¥38.11 Million ≈ $5.58 Million	0.086x	-73.22%
2011-12-31	CN¥378.47 Million ≈ $55.38 Million	CN¥121.67 Million ≈ $17.80 Million	0.321x	--

About Ningbo Menovo Pharm Co Ltd

SHG:603538 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.35 Billion

CN¥9.23 Billion CNY

Market Cap Rank

#7825 Global

#1855 in China

Share Price

CN¥38.02

Change (1 day)

-2.56%

52-Week Range

CN¥16.78 - CN¥68.50

All Time High

CN¥68.50